Psilocybin
Psilocybin 是目前在国外临床研究中出现的一款新药或疗法，主要研究方向为Major Depression、Depression、Parkinson's Disease (PD)、Transdiagnostic。下面汇总了它当前在全球正在招募患者的研究，以及中国患者可以走的申请途径。
24 项
全球在招研究
4 项
已进入 III/IV 期
6 个
开展国家和地区
暂未检索到
中国境内设点
药品与企业信息
研发企业
- VA Office of Research and Development
- Yale University
- Bruyère Health Research Institute.
- Khyber Medical University Peshawar
- Johns Hopkins University
- University of California, Berkeley
- University Hospital, Basel, Switzerland
- Hadassah Medical Organization
汇总自相关试验登记的主要申办方；研究机构申办时会显示相应机构名称。
生产企业
公开药品批准资料或正式说明书暂未提供明确的生产企业信息。
研发企业与生产企业可能不是同一家。研究阶段药品可能尚未公布生产企业；生产企业仅取自美国上市原研药说明书所列企业（不含仿制药），不作推测；仅在其他国家上市的药品暂无法显示。
主要开展国家和地区
美国、加拿大、Pakistan、瑞士、Israel、奥地利
正在招募患者的 Psilocybin 研究
Psilocybin as a Treatment for Chronic Pain in Smokers
早期 I 期招募中美国NCT07118332Psilocybin Microdose for Psychological and Existential Distress in Palliative Care (PSYCHED-PAL-RCT)
III 期招募中加拿大NCT07063862Effect of Psilocybin and Structured Integrated Reframing Therapy on Gut-Brain Axis Biomarkers and Depression in Major Depressive Disorder
III 期招募中PakistanNCT07703722Outpatient Buprenorphine Induction With Psilocybin for Opioid Use Disorder
II 期招募中美国NCT06067737Investigating the Persisting Effects of a Single Dose of Psilocybin on Structural Plasticity in Healthy Older Adults
I 期招募中美国NCT06367738Direct Comparison of Altered States of Consciousness Induced by LSD, Psilocybin, and DMT in Healthy Participants
I 期招募中瑞士NCT06899334Safety and Psychological Effects of Psilocybin and D-Serine Formulation in Healthy Volunteers
I 期招募中IsraelNCT07079930The ENHANCE Study: taVNS and Psilocybin
I 期招募中美国NCT05866471Psilocybin-assisted Therapy for Comorbid Major Depressive Disorder and Alcohol Use Disorder
II 期招募中加拿大NCT07405606RCT of Psilocybin-assisted CBT for Depression
I 期 / II 期招募中美国NCT07281352Investigation of Psychedelic Effects in Psychoactive Substances
I 期招募中美国NCT06772753Elucidating the Relevance of the Psychedelic Experience to Psilocybin's Anti-Anhedonic Effects
I 期招募中奥地利NCT07490353Psilocybin-Assisted Therapy
II 期招募中美国NCT07332143Redefine Study: A Study Evaluating the Efficacy, Safety, and Tolerability of COMP360 in Participants With Post-traumatic Stress Disorder
II 期 / III 期招募中美国加拿大NCT07570654Investigation to Understand and Optimize Psilocybin
II 期招募中美国NCT06512194Study of Psilocybin Assisted Psychotherapy to Address Fear of Recurrence
I 期招募中美国NCT06430541TRIPS - Treatment to Improve Depression and/or Anxiety Using Psilocybin-assisted Psychotherapy in Cancer Survivors
II 期招募中美国NCT06801041Exploration of Synaptotrophic Effects of Psilocybin in Opioid Use Disorder (OUD)
I 期招募中美国NCT06160284Psilocybin-Assisted Psychotherapy for Alcohol Use Disorder
II 期招募中加拿大NCT05995769Psilocybin Therapy in Advanced Cancer
II 期 / III 期招募中美国NCT05398484Psilocybin for Chronic Pelvic Pain (CPP) in Women: A Pilot Feasibility Study
I 期招募中美国NCT06988319Psilocybin Efficacy With or Without Pimavanserin Pretreatment
I 期 / II 期招募中美国NCT07610135Psilocybin-facilitated Treatment for Chronic Pain
早期 I 期招募中美国NCT05068791Wellcome Leap Psilocybin for OUD
II 期招募中美国NCT06786325
中国患者怎么争取用上这款药
目前境内暂未检索到设点，下面几条途径是更现实的选择，每条都有详细的中文做法。
查看完整申请指南同类方向的其他在研新药
本页信息整理自 ClinicalTrials.gov 公开登记数据，仅供参考，不构成医疗建议；是否适合使用该药物，请以专业医生和研究团队的意见为准。